Literature DB >> 19074113

Treatment of acute lymphoblastic leukemia in children and adolescents: peaks and pitfalls.

Nita L Seibel1.   

Abstract

Survival of children with acute lymphoblastic leukemia (ALL) is often described as the success story for oncology. The improvements in the treatment of ALL represent the work of cooperative groups at their best. Fifty years ago a pediatric oncologist would have never considered using the term "cure" in a discussion with a family whose child was diagnosed with ALL. Today the term is not only used in the initial discussion but referred to frequently thereafter. However, as we all know, cure is not assured and is not obtained without sequelae. This review will focus on the improvements in treatment for newly diagnosed ALL in children and adolescents according to risk group and some of the challenges that remain despite the improved outcome.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19074113     DOI: 10.1182/asheducation-2008.1.374

Source DB:  PubMed          Journal:  Hematology Am Soc Hematol Educ Program        ISSN: 1520-4383


  7 in total

1.  Response to exogenous gonadotropins in the unresponsive ovary syndrome.

Authors:  P A Zourlas
Journal:  Int J Gynaecol Obstet       Date:  1975       Impact factor: 3.561

Review 2.  Effect of ITPA Polymorphism on Adverse Drug Reactions of 6-Mercaptopurine in Pediatric Patients with Acute Lymphoblastic Leukemia: A Systematic Review and Meta-Analysis.

Authors:  Yeonhong Lee; Eun Jeong Jang; Ha-Young Yoon; Jeong Yee; Hye-Sun Gwak
Journal:  Pharmaceuticals (Basel)       Date:  2022-03-29

Review 3.  DENTAL CONSIDERATIONS FOR LEUKEMIC PEDIATRIC PATIENTS: AN UPDATED REVIEW FOR GENERAL DENTAL PRACTITIONER.

Authors:  Kholoud A Lowal; Nader Ahmed Alaizari; Bassel Tarakji; Waleed Petro; Khaja Amjad Hussain; Mohamed Abdullah Alsakran Altamimi
Journal:  Mater Sociomed       Date:  2015-10-05

4.  Leukemia cancer mortality trend in iran, from 1995 to 2004.

Authors:  Zeinab Fazeli; Mohamad Amin Pourhoseingholi; Mohsen Vahedi; Alireza Abadi; Fatemeh Sadat Fazeli Bavand-Pour; Ahmad Reza Baghestani
Journal:  Iran J Cancer Prev       Date:  2013

5.  Pegylated-asparaginase during induction therapy for adult acute lymphoblastic leukaemia: toxicity data from the UKALL14 trial.

Authors:  B Patel; A A Kirkwood; A Dey; D I Marks; A K McMillan; T F Menne; L Micklewright; P Patrick; S Purnell; C J Rowntree; P Smith; A K Fielding
Journal:  Leukemia       Date:  2016-08-02       Impact factor: 11.528

6.  Direct and indirect costs of families with a child with acute lymphoblastic leukaemia in an academic hospital in China: a cross-sectional survey.

Authors:  Yijiong Ren; Xin Li
Journal:  BMJ Open       Date:  2019-07-18       Impact factor: 2.692

7.  Microfluidic Device for On-Chip Immunophenotyping and Cytogenetic Analysis of Rare Biological Cells.

Authors:  Kumuditha M Weerakoon-Ratnayake; Swarnagowri Vaidyanathan; Nicholas Larky; Kavya Dathathreya; Mengjia Hu; Jilsha Jose; Shalee Mog; Keith August; Andrew K Godwin; Mateusz L Hupert; Malgorzata A Witek; Steven A Soper
Journal:  Cells       Date:  2020-02-24       Impact factor: 6.600

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.